TY  - GEN
AU  - Lv,Chao
AU  - Ma,Yuanyuan
AU  - Feng,Qin
AU  - Fang,Fang
AU  - Bai,Hua
AU  - Zhao,Bingtian
AU  - Yan,Shi
AU  - Wu,Nan
AU  - Zheng,Qingfeng
AU  - Li,Shaolei
AU  - Chen,Jinfeng
AU  - Wang,Jia
AU  - Feng,Yuan
AU  - Wang,Yuzhao
AU  - Pei,Yuquan
AU  - Fang,Jian
AU  - Yang,Yue
TI  - A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma
SN  - 1477-7819
PY  - 2013///1219
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cisplatin
KW  - administration & dosage
KW  - Crown Ethers
KW  - DNA-Binding Proteins
KW  - Deoxycytidine
KW  - Endonucleases
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Induction Chemotherapy
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Pilot Projects
KW  - Prognosis
KW  - Quinazolines
KW  - RNA, Messenger
KW  - Real-Time Polymerase Chain Reaction
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Ribonucleoside Diphosphate Reductase
KW  - Tumor Suppressor Proteins
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1477-7819-11-96
ER  -